Artificial Lung - Medical Devices Pipeline Assessment, 2018

  • ID: 4465600
  • Report
  • 37 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • ALung Technologies Inc
  • Breethe, Inc.
  • Haemair Ltd
  • Lung Biotechnology PBC
  • MedArray Inc.
  • Miromatrix Medical Inc
  • MORE
Artificial Lung - Medical Devices Pipeline Assessment, 2018

Summary

The author's Medical Devices sector report, “Artificial Lung - Medical Devices Pipeline Assessment, 2018" provides an overview of Artificial Lung currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Artificial Lung pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Artificial Lung under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Artificial Lung and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Artificial Lung under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ALung Technologies Inc
  • Breethe, Inc.
  • Haemair Ltd
  • Lung Biotechnology PBC
  • MedArray Inc.
  • Miromatrix Medical Inc
  • MORE
1 Table of Contents

2 Introduction
2.1 Artificial Lung Overview

3 Products under Development
3.1 Artificial Lung - Pipeline Products by Stage of Development
3.2 Artificial Lung - Pipeline Products by Territory
3.3 Artificial Lung - Pipeline Products by Regulatory Path
3.4 Artificial Lung - Pipeline Products by Estimated Approval Date
3.5 Artificial Lung - Ongoing Clinical Trials

4 Artificial Lung - Pipeline Products under Development by Companies
4.1 Artificial Lung Companies - Pipeline Products by Stage of Development
4.2 Artificial Lung - Pipeline Products by Stage of Development

5 Artificial Lung Companies and Product Overview
5.1 ALung Technologies Inc Company Overview
5.1.1 ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Breethe, Inc. Company Overview
5.2.1 Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 Case Western Reserve University Company Overview
5.3.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
5.4 Haemair Ltd Company Overview
5.4.1 Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.5 Lung Biotechnology PBC Company Overview
5.5.1 Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview
5.6 McGowan Institute for Regenerative Medicine Company Overview
5.6.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview
5.7 MedArray Inc. Company Overview
5.7.1 MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.8 Michigan Critical Care Consultants, Inc. Company Overview
5.8.1 Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.9 Miromatrix Medical Inc Company Overview
5.9.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 The Charles Stark Draper Laboratory Inc Company Overview
5.10.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 University of California San Francisco Company Overview
5.11.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
5.12 University of Michigan Company Overview
5.12.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
5.13 University of Pittsburgh Company Overview
5.13.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
5.14 Xenios AG Company Overview
5.14.1 Xenios AG Pipeline Products & Ongoing Clinical Trials Overview

6 Artificial Lung- Recent Developments
6.1 Sep 27, 2017: ALung Receives IDE Approval to Conduct VENT-AVOID Trial of the Hemolung RAS for the US Market
6.2 Apr 25, 2017: ALung Submits IDE Application to FDA Seeking Approval to Conduct Pivotal Study of the Hemolung RAS

7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Artificial Lung - Pipeline Products by Stage of Development
Table 2: Artificial Lung - Pipeline Products by Territory
Table 3: Artificial Lung - Pipeline Products by Regulatory Path
Table 4: Artificial Lung - Pipeline Products by Estimated Approval Date
Table 5: Artificial Lung - Ongoing Clinical Trials
Table 6: Artificial Lung Companies - Pipeline Products by Stage of Development
Table 7: Artificial Lung - Pipeline Products by Stage of Development
Table 8: ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Hemolung RAS - Product Status
Table 10: Hemolung RAS - Product Description
Table 11: ALung Technologies Inc - Ongoing Clinical Trials Overview
Table 12: Hemolung RAS - A Prospective, Multi-center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support
Table 13: Hemolung RAS - Extra-corporeal CO2 Removal as an Adjunct to Non-Invasive Ventilation in Acute Severe Exacerbations of COPD
Table 14: Hemolung RAS - Physiological Study of Minimally Invasive Extracorporeal CO2 Removal in Exacerbations of COPD Requiring Invasive Mechanical Ventilation
Table 15: Hemolung RAS - Protective Ventilation with Veno-venous Lung Assist in Respiratory Failure
Table 16: Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 17: OXY-1 - Product Status
Table 18: OXY-1 - Product Description
Table 19: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Portable Artificial Lung - Product Status
Table 21: Portable Artificial Lung - Product Description
Table 22: Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Portable Artificial Lung - Product Status
Table 24: Portable Artificial Lung - Product Description
Table 25: Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Implantable Artificial Lung - Product Status
Table 27: Implantable Artificial Lung - Product Description
Table 28: McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Biohybrid Artificial Lung - Product Status
Table 30: Biohybrid Artificial Lung - Product Description
Table 31: Chronic Artificial Lung - Product Status
Table 32: Chronic Artificial Lung - Product Description
Table 33: MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Artificial Lung Fiber - Product Status
Table 35: Artificial Lung Fiber - Product Description
Table 36: Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 37: BioLung - Product Status
Table 38: BioLung - Product Description
Table 39: Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Miromatrix Artificial Lung - Product Status
Table 41: Miromatrix Artificial Lung - Product Description
Table 42: The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Silicone-Based Microfluidic Artificial Lung - Product Status
Table 44: Silicone-Based Microfluidic Artificial Lung - Product Description
Table 45: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Neonatal ECMO Device - Product Status
Table 47: Neonatal ECMO Device - Product Description
Table 48: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
Table 49: M-Lung - Product Status
Table 50: M-Lung - Product Description
Table 51: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
Table 52: Paracorporeal Ambulatory Assist Lung - Product Status
Table 53: Paracorporeal Ambulatory Assist Lung - Product Description
Table 54: Xenios AG Pipeline Products & Ongoing Clinical Trials Overview
Table 55: i-lung - Product Status
Table 56: i-lung - Product Description
Table 57: Xtralung - Product Status
Table 58: Xtralung - Product Description
Table 59: Glossary

List of Figures
Figure 1: Artificial Lung - Pipeline Products by Stage of Development
Figure 2: Artificial Lung - Pipeline Products by Territory
Figure 3: Artificial Lung - Pipeline Products by Regulatory Path
Figure 4: Artificial Lung - Pipeline Products by Estimated Approval Date
Figure 5: Artificial Lung - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • ALung Technologies Inc
  • Breethe, Inc.
  • Case Western Reserve University
  • Haemair Ltd
  • Lung Biotechnology PBC
  • McGowan Institute for Regenerative Medicine
  • MedArray Inc.
  • Michigan Critical Care Consultants, Inc.
  • Miromatrix Medical Inc
  • The Charles Stark Draper Laboratory Inc
  • University of California San Francisco
  • University of Michigan
  • University of Pittsburgh
  • Xenios AG
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll